CAVALLARO, Lucas Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 728
EU - Europa 534
AS - Asia 279
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 1
Totale 1.548
Nazione #
US - Stati Uniti d'America 721
CN - Cina 229
IE - Irlanda 223
SE - Svezia 197
IT - Italia 51
TR - Turchia 34
BE - Belgio 19
FI - Finlandia 17
DE - Germania 13
IR - Iran 12
CA - Canada 7
EU - Europa 6
RO - Romania 3
HR - Croazia 2
HU - Ungheria 2
IN - India 2
NL - Olanda 2
BR - Brasile 1
CZ - Repubblica Ceca 1
FR - Francia 1
GB - Regno Unito 1
JP - Giappone 1
MD - Moldavia 1
NO - Norvegia 1
SG - Singapore 1
Totale 1.548
Città #
Chandler 307
Dublin 211
Nanjing 59
Dearborn 55
Beijing 44
Princeton 30
Izmir 28
Ann Arbor 23
Brussels 19
Ashburn 17
Helsinki 17
Wilmington 17
Parma 14
San Mateo 14
Hefei 13
Nanchang 13
Shenyang 12
Tianjin 12
Changsha 11
Kunming 9
Jiaxing 8
Jinan 8
Norwalk 7
Bremen 6
Kocaeli 6
Chengdu 5
Guangzhou 5
Hebei 5
Menlo Park 5
Toronto 5
Zanjan 5
Cambridge 4
Hangzhou 4
Ningbo 4
Andover 3
Augusta 3
Frattamaggiore 3
Grafing 3
Houston 3
Rio Saliceto 3
Sacramento 3
Timisoara 3
Budapest 2
Cornaredo 2
Falls Church 2
Fremont 2
Leawood 2
Padova 2
Philadelphia 2
Sezze 2
Taizhou 2
Washington 2
Zagreb 2
Bangalore 1
Baotou 1
Borås 1
Brno 1
Changchun 1
Chisinau 1
Des Moines 1
Duncan 1
Fuzhou 1
Glasgow 1
Haikou 1
Harbin 1
Los Angeles 1
Mumbai 1
Orange 1
Oslo 1
Portland 1
Quzhou 1
Rockville 1
Shaoxing 1
Stockholm 1
Suzzara 1
São Paulo 1
Tokyo 1
Trumbull 1
Winnipeg 1
Woodbridge 1
Wuhan 1
Zhengzhou 1
Totale 1.077
Nome #
Changes in surgical behaviors during the CoviD-19 pandemic. The SICE CLOUD19 Study 114
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 65
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 62
Does chronic hypercalcemia influence serum pepsinogens levels? 61
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 61
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 59
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 57
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 56
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 54
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 52
PA.27 GASTRO PANEL® FOR DETECTION OF ATROPHIC GASTRITIS: THE “PARMA MODEL” 52
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 52
T1979 Pepsinogen II As Marker of Inflammation in H.P Infection and in NSAIDs Damage 51
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 50
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 50
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 50
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 49
Gastro panel® for detection of atrophic gastritis: The “Parma model” 49
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 49
Serum pepsinogen II for early assessment of success of H. pylori eradication 49
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 45
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 43
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 43
A new curcumin-based one week therapy for eradication of H. pylori infection 42
Cancro gastrico e Helicobacter pylori 42
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 41
Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study 38
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 35
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study 33
La diagnosi sierologica delle gastriti croniche atrofiche 32
null 30
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 27
Totale 1.593
Categoria #
all - tutte 4.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201982 0 0 0 0 10 2 2 2 5 1 38 22
2019/2020256 90 37 3 1 9 45 30 6 11 14 10 0
2020/202149 1 0 3 0 0 0 0 0 3 30 8 4
2021/2022244 7 11 1 44 29 6 12 11 10 15 32 66
2022/2023853 67 99 71 86 56 100 5 67 263 5 31 3
2023/202469 11 21 7 6 24 0 0 0 0 0 0 0
Totale 1.593